TScan Therapeutics (TCRX) Other Non Operating Income (2022 - 2026)
TScan Therapeutics' Other Non Operating Income came in at $134,000 for Q2 2026, down 92.1% from $1.7 million a year earlier and down 71.7% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Other Non Operating Income (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TScan Therapeutics reported Other Non Operating Income of $2.83 million, down 62.1% year-over-year; for FY2025, it was $6.05 million, down 17.4% from FY2024.
- Other Non Operating Income carries a four-year compound annual growth rate of 340.9% (FY2021 to FY2025).
- Going back by year, Other Non Operating Income was $7.32 million in FY2024 (+72.7%), $4.24 million in FY2023 (+921.7%), $415,000 in FY2022 and $16,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Other Non Operating Income since Q4 2022.
- Year-over-year, Other Non Operating Income has declined for five consecutive quarters, with an average decline of 21.7% over the last eight quarters.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q1 2024 (growth of 583.9%), and the weakest in Q2 2026 (a decline of 92.1%).
- Business Quant data shows TCRX's Other Non Operating Income at $473,000 (Q1 2026), $881,000 (Q4 2025) and $1.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | TScan Therapeutics | 41.58 Mn | 41.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134,000.00 |
| Mar 31, 2026 | 473,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 565,000.00 |
| Mar 31, 2023 | 180,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 149,000.00 |
| Mar 31, 2022 | 7,000.00 |
API Access
TScan Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();